ArticleCancer medicine2026

Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score-Matched Real-World Analysis.

Anna Homeniuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.